Predictions
TCR2 Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.68
16.10.22
16.10.22
-
16.10.23
16.10.23
-6.83%
30.10.22
30.10.22
Could be very worthwhile Investment >20% year
Hypoport SE
Start price
Target price
Perf. (%)
€86.20
16.10.22
16.10.22
€90.00
16.10.23
16.10.23
-4.58%
17.10.22
17.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Standard Investments for future growth
Energiekontor
Start price
Target price
Perf. (%)
€87.50
15.10.22
15.10.22
€95.00
15.10.23
15.10.23
-17.49%
16.10.23
16.10.23
Could be worthwhile Investment >10% per year
CropEnergies AG
Start price
Target price
Perf. (%)
€14.22
15.10.22
15.10.22
€15.50
15.10.23
15.10.23
6.75%
25.10.22
25.10.22
Could be worthwhile Investment >10% per year
Delignit AG
Start price
Target price
Perf. (%)
€5.10
15.10.22
15.10.22
€7.00
15.10.23
15.10.23
-17.25%
16.10.23
16.10.23
Could be worthwhile Investment >10% per year
Applied DNA Sciences Inc.
Start price
Target price
Perf. (%)
€2.38
15.10.22
15.10.22
€1.00
15.10.23
15.10.23
-24.07%
29.10.22
29.10.22
Significant cyclical dependencies
Little known brand
Revenue decline/stagnation expected
ROE lower than 10% per year
Peloton Interactive Inc.
Start price
Target price
Perf. (%)
€7.52
15.10.22
15.10.22
€3.00
15.10.23
15.10.23
7.99%
29.10.22
29.10.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.54
15.10.22
15.10.22
€2.00
15.10.23
15.10.23
-0.88%
29.10.22
29.10.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
First Wave BioPharma Inc.
Start price
Target price
Perf. (%)
€8.22
15.10.22
15.10.22
€0.000
15.10.23
15.10.23
2.13%
29.10.22
29.10.22
Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
Banca Monte dei Paschi di Siena SpA
Start price
Target price
Perf. (%)
€2.05
15.10.22
15.10.22
€4.00
15.10.23
15.10.23
-4.85%
29.10.22
29.10.22
EBIT decline/stagnation expected
High valuation
negative Cash Flow expected
Business model of the past or high risk
Db X-trackers FTSE 100 Short Daily Ucits Etf
Start price
Target price
Perf. (%)
€3.70
15.10.22
15.10.22
-
15.10.23
15.10.23
-7.06%
11.11.22
11.11.22
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.63
14.10.22
14.10.22
€5.00
14.10.23
14.10.23
-84.59%
15.10.23
15.10.23
Could be worthwhile Investment >10% per year
Moderna Inc.
Start price
Target price
Perf. (%)
€137.82
13.10.22
13.10.22
-
13.10.23
13.10.23
5.79%
23.02.23
23.02.23
Significant cyclical dependencies
Higher risks for its business
B.R.A.I.N. Biotechnology Research and Information Network AG
Start price
Target price
Perf. (%)
€4.98
13.10.22
13.10.22
-
13.10.23
13.10.23
-18.27%
14.10.23
14.10.23
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.55
13.10.22
13.10.22
€2.30
13.10.23
13.10.23
42.55%
19.11.22
19.11.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Applied Materials Inc.
Start price
Target price
Perf. (%)
€80.66
13.10.22
13.10.22
€140.00
13.10.23
13.10.23
66.23%
14.10.23
14.10.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group